Lansoprazole for Subgroups of Functional Dyspepsia
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Pharmacotherapy for functional dyspepsia remains unsatisfactory. Previous randomized trials
reported conflicting results on clinical effectiveness of proton pump inhibitor in patients
with functional dyspepsia. This study aims to examine whether lansoprazole 15mg is more
effective than placebo for functional dyspepsia in Taiwanese patients, and to investigate the
association between subgroups of patients and therapeutic response.